Tian Sun
Guangxi Key Laboratory Of Molecular Medicine In Liver Injury And Repair
Guilin, 541001, China
Guilin, 541001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation.
Journal: Frontiers in bioscience (Landmark edition)
Published: September 26, 2025
GBA3 as a regulator of sphingolipid metabolism in the progression of hepatocellular carcinoma.
Journal: Journal of gastrointestinal oncology
Published: July 16, 2025
Mogroside V protects against acetaminophen-induced liver injury by reducing reactive oxygen species and c-jun-N-terminal kinase activation in mice.
Journal: World journal of hepatology
Published: December 24, 2024
Complement activation targeted inhibitor C2-FH ameliorates acetaminophen-induced liver injury in mice.
Journal: World journal of hepatology
Published: April 28, 2024
S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression.
Journal: Cell death & disease
Published: April 04, 2022
GBA1-dependent membrane glucosylceramide reprogramming promotes liver cancer metastasis via activation of the Wnt/β-catenin signalling pathway.
Journal: Cell death & disease
Published: January 27, 2022
Serum AKR1B10 predicts the risk of hepatocellular carcinoma - A retrospective single-center study.
Journal: Gastroenterologia y hepatologia
Published: February 28, 2019
Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection.
Journal: OncoTargets and therapy
Published: September 22, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026